Unknown

Dataset Information

Efficacy and safety of AM-101 in the treatment of acute inner ear tinnitus--a double-blind, randomized, placebo-controlled phase II study.


ABSTRACT:

Objective

To evaluate the efficacy and safety of intratympanic AM-101 in patients with persistent acute inner ear tinnitus after acute acoustic trauma, idiopathic sudden sensorineural hearing loss (ISSNHL), or acute otitis media.

Study design

Prospective, double-blind, randomized, placebo-controlled study with follow-up visits on Days 7, 30, and 90.

Setting

Twenty-eight European sites (academic tertiary referral centers and private ENT practices).

Patients

248 patients aged 16 to 65 years.

Interventions

Three intratympanic injections of AM-101 (0.27 or 0.81 mg/ml) or placebo over 3 consecutive days.

Main outcome measures

Efficacy was assessed by changes in minimum masking level (MML; primary end point), loudness match, tinnitus loudness, tinnitus

SUBMITTER: van de Heyning P 

PROVIDER: S-EPMC3966923 | biostudies-literature | 2014 Apr

REPOSITORIES: biostudies-literature